Brief: Purapharm Corp Expects Both HY Revenue And Profit To Increase
Aug 13 (Reuters) - PuraPharm Corp Ltd 1498.HK :
* EXPECTED THAT BOTH OF GROUP'S REVENUE AND PROFIT FOR SIX
MONTHS
PERIOD ENDED 30 JUNE 2018 WILL RECORD AN INCREASE OF MORE THAN
30%
* EXPECTED RESULT DUE TO INCREASE IN SALES OF GROUP'S CHINA
CONCENTRATED CHINESE MEDICINE GRANULES SEGMENT
Source text for Eikon: ID:nHKS29KJFs
Further company coverage: 1498.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PuraPharm
See all newsBrief: Purapharm Corp To Issue Convertible Bonds With Principal Amount Of HK$20 MLN
Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
Brief: Purapharm Says Kam Biu Tsoi, Alvin Appointed As Executive Director
Brief: Purapharm Corp Announces Lapse Of Disposal Agreement
Brief: PuraPharm Corp To Dispose Of Accounts Receivables At HK$15 Mln